Skip to Content

'
Barbara Jane O'Brien, M.D.

Present Title & Affiliation

Primary Appointment

Assistant Professor, Department of Neuro-Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Education & Training

Degree-Granting Education

2008 St George's University School of Medicine, Grenada, West Indies, MD, Magna Cum Laude, Medicine
2001 Tulane University, Newcomb College, New Orleans, LA, BS, Ecology and Evolutionary Biology/Art History

Postgraduate Training

7/2012-2/2014 Clinical Fellowship, Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
2/2011 Visiting Residency, Neuro-Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY
7/2009-6/2012 Clinical Residency, Neurology, University of Connecticut/Hartford Hospital, Farmington, CT
6/2008-6/2009 Clinical Internship, Internal Medicine, University of Connecticut, Farmington, CT
9/2002-5/2003 Post-Baccalaureate, Pre-Medical Program, University of Miami, Coral Gables, FL

Board Certifications

9/2012 American Board of Psychiatry and Neurology

Experience/Service

Administrative Appointments/Responsibilities

EPIC Electronic Health Record Officer, Department of Neuro-Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 4/2014-present

Honors and Awards

2014 William James Miller Endowed Fellowship Award, MD Anderson Cancer Center
2012 Virginia Scola Compassionate Physician Award, University of Connecticut Neurology Residency Program

Selected Publications

Invited Articles

1. O'Brien BJ, Colen RR. Post-treatment Imaging Changes in Primary Brain Tumors. Curr Oncol Rep 16(8):397, 8/2014. PMID: 24997979.

Abstracts

1. Pawar TU, Ladha HA, Mandel JA, Gilbert MR, O'Brien BA, Hamza MO, Armstrong TE. Adverse Effects of Bevacizumab in Brain Tumor Patients. Neuro-Oncology In: Proceeding from the 19th Annual Scientific Meeting of the Society for Neuro-Oncology, (SNO) Miami, FL, November 13-16,2014 16(Supplement 5):49 (#CN-15), 11/2014.
2. Ladha HA,Pawar TU, Gilbert MA, O'Brien BA, Conrad CH, Fields MA, Hanna TE, Loch CA, Armstrong TE. Wound Healing Complications In A Series Of Brian Tumor Patients On Bevacizumab. Neuro-Oncology In: Proceeding from the 19th Annual Scientific Meeting of the Society for Neuro-Oncology, (SNO) Miami, FL, November 13-16,2014 16(Supplement 5):5, 11/2014.
3. O’Brien BJ, Mandel JJ, Tummala S, de Groot JF. Non-convulsive Status Epilepticus in Cancer Patients with Altered Mental Status. Journal of Clinical Oncology 32 (#e13028), 6/2014.
4. Hamza MA, O’Brien BJ, Mandel JJ, de Groot JF. Survival Outcomes of Patients with Recurrent Anaplastic Glioma Treated with Bevacizumab. Neuro-Oncology 15(iii):98-135 (#NO-051), 11/2013.

Book Chapters

1. Weathers SP, O’Brien BJ, Yung WK, de Groot JF. Chapter 19:Targeted Therapy in Solid Tumors: Brain. In: Targeted Therapy in Cancer. Wiley. In Press.
2. O’Brien BJ, Gilbert MR. Primary Brain Tumors. In: Cancer Consult: Expertise for Clinical Practice. Section 2 Chapter 70. Ed(s) SA Abutalib, M Markman. Wiley-Blackwell Health Sciences, 449-456, 2014. ISBN: 978-1-118-58921-2.
3. O’Brien BJ, Yung WK, de Groot JF. Small-molecule-based Therapies. In: Essentials of Neuro-oncology. Section VI Chapter 22, 3rd. Ed(s) Berger, MS and Bernstein, M. Thieme, 234-244, 2014. ISBN: 9781604068832.

Last updated: 11/25/2014